All GLG News Analyses Filed Under: Ophthalmology
Posted December 18, 2006
AMO Acted Responsibly.
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
AMO's voluntary recall of Complete MoisturePLUS (November 21, 2006) represents a company acting in the best interest of its consumers. The bacterial contamination of products associated with its manufacturing line in China is an unfortunate occurrence, but one that was handled with the utmost responsibility...
Posted December 11, 2006A Tale of Two Recalls
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: Steve Rubinstein, Optometrist Sound Shore Vision Care
The new product recall of Complete manufactured by AMO is very different from the Renu with MoistureLoc product recall manufactured by Bausch & Lomb (B&L). Both recalls will have an impact on the health and safety of Americans and the world public. Will these product recalls have a long lasting...
Posted December 5, 2006
Eye drops and preservatives
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
While Benzalkonium Chloride (BAK) is the most common eye drop preservative (85% of all drops) it has an adverse effect on the ocular surface. With prolonged use i.e. dry eyes and glaucoma preservative toxicity because a serious problem. Currently uni-dose artificial tears are available but...
Posted November 30, 2006
Contact lens solution options are shrinking.
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
Analysis of: Another Contact-Lens Solution Recalled | www.newsinferno.com
Author: GLG Member Program Contributor
While the recall of Complete is limited, it will undoubtly cause most practioners to tell their patients to discontinue all of AMO's Complete product use.As with the Renu recall, patients will change to different products and will likely not return, unless major product changes are made--in both...
Posted November 20, 2006Laser to drusen trial
Analysis of: Laser Treatment Ineffective In Preventing Vision Loss In Early Age-Related Macular Degeneration | www.pharma-lexicon.com
Author: Gaurav Shah, Associate Professor of Ophthalmology Washington University Medical Center
It is not surprising that laser therapy is not effective for patients with macular degeneration. Initially there was a significant interest in this therapy, but as this well designed trial has shown us that thermal treatment is not the answer for dry ARMD. AREDS I and AREDS II are now the most important...
Posted November 17, 2006
AMD Prevention
Analysis of: Laser Treatment Ineffective In Preventing Vision Loss In Early Age-Related Macular Degeneration | www.pharma-lexicon.com
Author: GLG Member Program Contributor
Analysis of: Laser Treatment Ineffective In Preventing Vision Loss In Early Age-Related Macular Degeneration | www.pharma-lexicon.com
Author: GLG Member Program Contributor
Prevention of disease progression remains an important goal for patients with early AMD. This high quality study, the Complications of AMD Prevention Trial, demonstrated no benefit for subjects receiving low intensity laser treatment. Other trials such as the National Eye Institute's AREDS...
Posted November 3, 2006AMO's Tecnis multifocal: A worthy adversary to Alcon's Restor
Analysis of: Multifocal IOL provides high-quality vision for patients | www.ophthalmologytimes.com
Author: Sanjay Rao, Medical Director Lakeside Eye Clinic
This article describes the experience of 3 European surgeons with the Tecnis multifocal intraocular lens. Currently, the only two FDA approved multifocal lenses in the U.S. are Alcon's Restor and AMO's Rezoom. The Tecnis multifocal is unique among current multifocal options in that it incorporates...
Posted November 1, 2006New applications for Intralase technology
Analysis of: Femtosecond laser technology enhances corneal grafting | www.OSNSuperSite.com
Author: Sanjay Rao, Medical Director Lakeside Eye Clinic
This article describes how the Intralase laser can be used to perform corneal transplantation. The Intralase femtosecond laser has traditionally been utilized to create a corneal flap in the LASIK procedure. This article describes the experience of a team of Italian corneal surgeons utilizing...
Posted October 31, 2006
Is Bausch & Lomb Doing Enough to Warn Retailers, Patients of MoisturLoc's Potential Danger?
Analysis of: Recalled ReNu with MoistureLoc Still Commands 2% of the Contact Lens Solution Market | www.newsinferno.com
Author: Darcy Ryan, Optometrist Hertzog Eye Associates
Is Bausch & Lomb Doing Enough to Warn Retailers, Patients of MoisturLoc's Potential Danger?
Analysis of: Recalled ReNu with MoistureLoc Still Commands 2% of the Contact Lens Solution Market | www.newsinferno.com
Author: Darcy Ryan, Optometrist Hertzog Eye Associates
Months after the worldwide recall of Bausch & Lomb's ReNu with MoisturLoc, this solution still holds a 2% market share (according to a recent survey by AC Nielsen Market Data).How is this possible? Is Bausch & Lomb not doing enough to inform doctors, retailers, and patients? No...but, are...
Posted October 27, 2006
1-800 Contacts Works on Development of New Contact Lens Packaging to Improve "Contact Lens Experience" - Improvement or Gimmick?
Analysis of: 1-800 Contacts pitches new lens | www.sltrib.com
Author: Darcy Ryan, Optometrist Hertzog Eye Associates
Previous
Page :
12 13 14 15 16 17 18 19 20 21 22211 to
220
of 2201-800 Contacts Works on Development of New Contact Lens Packaging to Improve "Contact Lens Experience" - Improvement or Gimmick?
Analysis of: 1-800 Contacts pitches new lens | www.sltrib.com
Author: Darcy Ryan, Optometrist Hertzog Eye Associates
1-800 Contacts, through its wholly-owned Clearlab subsidiary, based in Singapore, have come up with a new packaging design. They are also looking to manufacture its own lenses, called AquaSoft Singles, to be contained in this new packaging, for sale in the U.S. within the next 2 years.The...
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
CVS Escalates the Generic Price War
November 13, 2008
A closer look
November 11, 2008

